Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020-16 February 2021.

Haw, Nel Jason L; Cañal, Eugenia Mercedes R; Zuasula, Juanito; Loreche, Mary Jean; Bernadas, Jaime

Haw, Nel Jason L; Cañal, Eugenia Mercedes R; Zuasula, Juanito; Loreche, Mary Jean; Bernadas, Jaime.

Haw NJL; Health Sciences Program, Ateneo de Manila University, Quezon City, Philippines.
Cañal EMR; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.
Zuasula J; Center for Health and Development, Region 7 (Central Visayas Region), Department of Health, Cebu City, Philippines.
Loreche MJ; Center for Health and Development, Region 7 (Central Visayas Region), Department of Health, Cebu City, Philippines.
Bernadas J; Center for Health and Development, Region 7 (Central Visayas Region), Department of Health, Cebu City, Philippines.

Western Pac Surveill Response J ; 13(1): 1-3, 2022.

Article in English | MEDLINE | ID: covidwho-1771579

Subject(s)

COVID-19; SARS-CoV-2; COVID-19/epidemiology; Humans; Philippines/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Variants Limits: Humans Country/Region as subject: Asia Language: English Journal: Western Pac Surveill Response J Year: 2022 Document Type: Article Affiliation country: Wpsar.2022.13.1.883

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google